Ra Pharmaceuticals to Present at the UBS 2017 Global Healthcare Conference
May 16 2017 - 7:12AM
Business Wire
Ra Pharmaceuticals, Inc. (NASDAQ: RARX), a clinical stage
biopharmaceutical company focusing on the development of
next-generation therapeutics for the treatment of
complement-mediated diseases, today announced that Doug Treco, PhD,
President and Chief Executive Officer, will present at the UBS 2017
Global Healthcare Conference on Monday, May 22, 2017 at 10:00 a.m.
E.T. The conference is being held at the Grand Hyatt New York.
The presentation will be webcast live and can be accessed by
visiting the investor relations section of the Company’s website,
www.rapharma.com. A replay of the presentation will also be
available and archived on the site for three weeks.
About Ra Pharmaceuticals
Ra Pharmaceuticals is a clinical stage biopharmaceutical company
focusing on the development of next-generation therapeutics for
complement-mediated diseases. The Company discovers and develops
peptides and small molecules to target key components of the
complement cascade. For more information, please visit:
www.rapharma.com.
View source
version on businesswire.com: http://www.businesswire.com/news/home/20170516005391/en/
Investors:Ra Pharmaceuticals, Inc.Jennifer Robinson,
617-674-9873jrobinson@rapharma.comorMedia:Argot PartnersEliza
Schleifstein, 917-763-8106eliza@argotpartners.com
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Ra Pharmaceuticals (NASDAQ:RARX)
Historical Stock Chart
From Apr 2023 to Apr 2024